Recital 16, Directive (EU) 2025/2062

In forcesince 14 Oct 2025

The health and social risks associated with 2-MMC, NEP and 4-BMC are likely to share some similarities with other closely related synthetic cathinones and psychostimulants under international control. The available evidence and information on the health and social risks that the substances pose provide sufficient ground for including 2-MMC, NEP and 4-BMC in the definition of ‘drug’. Nevertheless, the risk assessment reports reveal also that many of the questions related to 2-MMC, NEP and 4-BMC that are posed by the lack of data on the risks to individual health, risks to public health and social risks could be answered through further research.